Clover Corp Ltd
CLV
Company Profile
Business description
Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe and the Americas. Majority of the revenue is derived from Australia/New Zealand.
Contact
39 Pinnacle Road
Altona North
MelbourneVIC3025
AUST: +61 383475000
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
31 July 2026
Employees
68
Stocks News & Analysis
stocks
AI isn’t an economic moat killer, but it will disrupt industries
How we’re rethinking companies’ competitive advantages in an AI-first world.
stocks
AI lands a blow on some Aussie stocks – yet stands to benefit others
AI is reshaping ASX tech moats - but some are more insulated than others.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,571.30 | 125.30 | -1.44% |
| CAC 40 | 7,696.94 | 29.26 | -0.38% |
| DAX 40 | 22,451.22 | 202.64 | -0.89% |
| Dow JONES (US) | 46,208.47 | 631.00 | 1.38% |
| FTSE 100 | 9,869.71 | 24.44 | -0.25% |
| HKSE | 25,063.71 | 681.24 | 2.79% |
| NASDAQ | 21,946.76 | 299.15 | 1.38% |
| Nikkei 225 | 52,252.28 | 736.79 | 1.43% |
| NZX 50 Index | 12,701.75 | 197.97 | -1.53% |
| S&P 500 | 6,581.00 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,379.40 | 125.20 | -1.47% |
| SSE Composite Index | 3,881.28 | 68.00 | 1.78% |